Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 36 (6), 986-987

Severe Recurrent Aphthous Stomatitis Treated With Adalimumab: A Case Report in a Teenage Patient


Severe Recurrent Aphthous Stomatitis Treated With Adalimumab: A Case Report in a Teenage Patient

Dario de Perosanz-Lobo et al. Pediatr Dermatol.


Recurrent aphthous stomatitis (RAS) is a chronic disorder of unknown etiology characterized by recurring ulcers involving the oral mucosa in patients with no other manifestations. It is a common cause of oral ulcers in children. In its major form, RAS can be a severe and disabling disorder due to pain and scarring, and poses a therapeutic challenge. Therapies for major RAS include prednisone, thalidomide, colchicine, and dapsone. However, many patients do not achieve adequate control of the disease with them (J Clin Diagn Res, 10, 2016 and ZE08). We report a case of severe RAS in a teenager with a dramatic response to adalimumab.

Keywords: RAS; TNF-α; adalimumab; anti-TNF; aphthous stomatitis.

Similar articles

See all similar articles



    1. Ranganath SP, Pai A. Is optimal management of recurrent aphthous stomatitis possible? A reality check. J Clin Diagn Res JCDR. 2016;10:ZE08-ZE13.
    1. Sánchez-Cano D, Callejas-Rubio JL, Ruiz-Villaverde R, Ortego-Centeno N. Recalcitrant, recurrent aphthous stomatitis successfully treated with adalimumab. J Eur Acad Dermatol Venereol JEADV. 2009;23:206.
    1. Hegde S, Ajila V, Babu S, et al. Evaluation of salivary tumour necrosis factor-alpha in patients with recurrent aphthous stomatitis. Eur Oral Res. 2019;52:157-161.
    1. Poddighe D, Romano M, Gattinara M, Gerloni V. Biologics for the treatment of juvenile idiopathic arthritis. Curr Med Chem. 2019;25(42):5860-5893.
    1. Poddighe D, Mukusheva Z, Dauyey K, Assylbekova M. Adalimumab in the treatment of pediatric Behçet's disease: case-based review. Rheumatol Int. 2019;3:1107-1112.

LinkOut - more resources